Normalization of hemoglobin level in patients with chronic kidney disease and anemia.
Explore this paper's citation graph
Summary
In patients with chronic kidney disease, early complete correction of anemia does not reduce the risk of cardiovascular events and there was no significant difference in the combined incidence of adverse events between the two groups.
- Type
- article
- Published
- 2006-11-16
- Cited by
- 2,127
- References
- 53
- Access
- Open access
- OpenAlex
- https://openalex.org/W2134487085
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:205089095
Keywords
Medicine, Kidney disease, Hemoglobin, Anemia, Normalization (sociology)
References
- Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.
- Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients.
- The impact of anemia on cardiomyopathy, morbidity, and and mortality in end-stage renal disease.
- Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure.
- Anemia in hemodialysis patients: variables affecting this outcome predictor.
- Vascular permeability factors in steroid-sensitive nephrotic syndrome and focal segmental glomerulosclerosis.
- Cardiovascular effects of recombinant human erythropoietin in predialysis patients.
- Improved survival in patients obtaining remission of nephrotic range albuminuria in diabetic nephropathy.
- The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients.
- Cardiovascular Mortality in Haemodialysis Patients Treated with Epoetin Beta – A Retrospective Study
- Progressive decline in renal function induces a gradual decrease in total hemoglobin and exercise capacity.
- Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study Report No. 26.
- The MOS 36-Item Short-Form Health Survey (SF-36)
- Correction of anemia with epoetin alfa in chronic kidney disease.
- Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD.
- KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.
- Progression of nephropathy in type 2 diabetic patients.
- Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy.
- Well-being and functional ability in uraemic patients before and after having started dialysis treatment.
- Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Cited by
- Target haemoglobin concentrations in chronic kidney disease.
- Adverse effects on hemostatic function of drugs used in hematologic malignancies.
- Dosing patterns, drug costs, and hematologic outcome in anemic patients with chronic kidney disease switching from darbepoetin alfa to epoetin alfa
- Erythropoietin Stimulates Normal Endothelial Progenitor Cell-Mediated Endothelial Turnover, but Attributes to Neovascularization Only in the Presence of Local Ischemia
- CERA: third-generation erythropoiesis-stimulating agent
- Erythropoietin and renoprotection
- Anemia and chronic heart failure: from pathophysiologic mechanisms to clinical trial designs
- Effectiveness and safety of recombinant human erythropoietin beta in maintaining common haemoglobin targets in routine clinical practice in Europe: the GAIN study
- Relative risk of death in UK haemodialysis patients in relation to achieved haemoglobin from 1999 to 2005: an observational study using UK Renal Registry data incorporating 30,040 patient-years of follow-up.
- ESAs in dialysis patients: are you a hedgehog or a fox?
- Update in Nephrology
- Neurologic complications of acute and chronic renal disease.
- Prevalence and Management of Anaemia in Renal Transplant Recipients: Data from Ten European Centres
- Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial.
- Renal Association Clinical Practice Guideline on Anaemia of Chronic Kidney Disease
- Darbepoetin alfa once every 2 weeks effectively maintained hemoglobin in dialysis patients in an observational study: Austrian cohort of ALTERNATE
- Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF)
- KDOQI US commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD.
- Influence of safety warnings on ESA prescribing among dialysis patients using an interrupted time series
- Anemia and heart failure a new pathway?
Related papers
- On Batch Orthogonalization Layers
- Extended Batch Normalization
- Controlling Covariate Shift using Equilibrium Normalization of Weights
- On normalization of inconsistency indicators in pairwise comparisons
- ANEMIA IN CHRONIC KIDNEY DISEASE PATIENTS
- Prevalence of Anemia in Chronic Kidney Disease in the United States
- Home Therapy to Reduce Office Visits for Patients with Chronic Kidney Disease and Anemia.